Shopping Cart

Imagion Biosystems September 2021 Investor Newsletter

Imagion Biosystems September 2021 Investor Newsletter

Imagion Biosystems is pleased to provide its investors with its September 2021 Investor Newsletter.

The newsletter details recent new company developments and activities, including:

  • Message from the CEO, Mr Robert Proulx;
  • Q&A with Jane Fox, Director of Breast Services at Monash Health, and Principal Investigator of the

    MagSense® HER2 breast cancer clinical study;

  • Expanding the MagSense® pipeline to brain cancer;
  • IBX SAB member Dr Andrew Scott Appointed to VCCC Alliance;
  • Imagion Biosystems 1H2021 Half-Year Report;
  • Employment of Chief Development Officer; and
  • Update on Nanoparticle Sales.

    Imagion Biosystems normally distributes this update as an e-newsletter. Investors can sign up to receive email updates at this link: http://ems.gs/3FuT0frcGxD

Please click to review the newsletter at ASX.

Related Articles

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.